Sanofi, Regeneron to restructure antibody collaboration for Kevzara, Praluent Farhat Nasim12 Dec 2019 9:20 AM ISTUnder the proposed restructuring, Sanofi is expected to gain sole global rights to Kevzara and sole ex-U.S. rights to Praluent. Regeneron is expected...
AstraZeneca-Daiichi trastuzumab deruxtecan halts cancer for months in first readout Medical Dialogues Bureau12 Dec 2019 9:05 AM IST"This is a totally unprecedented clinical benefit," Jose Baselga, AstraZeneca's head of oncology research and development said of the so-called...
Edelweiss Tokio Life creates new GUINNESS WORLD RECORDS for collecting highest pledges in a day Medical Dialogues Bureau12 Dec 2019 9:00 AM ISTEdelweiss Tokio Life observed November as Organ Donation Awareness Month, focused on educating, and mobilising support for this cause.New Delhi:...
Subscription of Piramal debentures by Canadian investor approved by CCI Medical Dialogues Bureau11 Dec 2019 12:28 PM ISTThe Competition Commission of India (CCI) in a tweet said it "approves the subscription of CCDs of Piramal Enterprises by CDPQ. Upon conversion, the...
Merck to acquire cancer drug developer ArQule for USD 2.7 billion Farhat Nasim11 Dec 2019 9:30 AM ISTNew Delhi: Merck, known as MSD outside the United States and Canada, and ArQule, Inc. recently announced that the companies have entered into a...
Transasia Bio-Medicals names Medtronic biz director Ravi Kaushik as new CEO Farhat Nasim11 Dec 2019 9:17 AM ISTPrior to this appointment at Transasia Bio-Medicals, Ravi Kaushik was Group Marketing Director - Asia Pacific & Country Business Director -...
Sanofi closes research in diabetes, cardiovascular diseases; narrows units to spur profit Medical Dialogues Bureau11 Dec 2019 9:15 AM ISTSanofi, which is due to further detail strategic plans to investors on Tuesday in Cambridge, Massachusetts, said it was targeting new cost savings of...
SETBACK: Correvio Pharma heart drug Brinavess fails to win USFDA panel backing Medical Dialogues Bureau11 Dec 2019 9:10 AM ISTThe panel voted 11-2 against approving Correvio Pharma's drug, Brinavess, citing serious safety risks, including low blood pressure and irregular...
Biohaven Pharma Alzheimers treatment Troriluzole to continue late-stage study Medical Dialogues Bureau11 Dec 2019 9:00 AM ISTBiohaven Pharmaceutical's study of its experimental Alzheimer's treatment, Troriluzole is being led by the Alzheimer's Disease Cooperative Study...
Roche secures CE Mark for Accu-Chek SugarView app for diabetes management Farhat Nasim10 Dec 2019 1:07 PM ISTNow officially classified as in-vitro diagnostics (IVD) software, the app will be made widely accessible by Roche first for certain smartphone models...
Dr Reddys unveils generic Deferasirox Tablets in US Farhat Nasim10 Dec 2019 12:53 PM ISTThe two different products launched by Dr Reddy's Labs in the US market are generic versions of Exjade (deferasirox) and Jadenu (deferasirox)...
Sanofi to acquire biotech firm Synthorx for USD 2.5 billion Medical Dialogues Bureau10 Dec 2019 11:15 AM IST"This acquisition ... is aligned with our goal to build our oncology franchise with potentially practice-changing medicines and novel combinations,"...
